Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatments for psoriasis and the risk of malignancy
Rita V. Patel, Lily Clark, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology (2009) Vol. 60, Iss. 6, pp. 1001-1017
Closed Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

Vitiligo: A comprehensive overview
Ali Alikhan, Lesley M. Felsten, Meaghan Daly, et al.
Journal of the American Academy of Dermatology (2011) Vol. 65, Iss. 3, pp. 473-491
Closed Access | Times Cited: 618
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
Kim Papp, C.E.M. Griffiths, Kenneth B. Gordon, et al.
British Journal of Dermatology (2013) Vol. 168, Iss. 4, pp. 844-854
Closed Access | Times Cited: 400
Psoriasis: Which therapy for which patient
Shivani B. Kaushik, Mark Lebwohl
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 1, pp. 27-40
Closed Access | Times Cited: 322
Epidemiology and Risk Factors of Melanoma
Stephanie Carr, Christina H. Smith, Jessica A. Wernberg
Surgical Clinics of North America (2019) Vol. 100, Iss. 1, pp. 1-12
Closed Access | Times Cited: 291
Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus
Gudula Kirtschig, K. H. Becker, Andreas R. Günthert, et al.
Journal of the European Academy of Dermatology and Venereology (2015) Vol. 29, Iss. 10
Open Access | Times Cited: 281
Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities
Inge M. G. J. Bronckers, Amy S. Paller, M. J. van Geel, et al.
Pediatric Drugs (2015) Vol. 17, Iss. 5, pp. 373-384
Open Access | Times Cited: 212
Secondary immunodeficiencies, including HIV infection
Javier Chinen, William T. Shearer
Journal of Allergy and Clinical Immunology (2009) Vol. 125, Iss. 2, pp. S195-S203
Open Access | Times Cited: 260
Genetics of pigmentation in skin cancer — A review
Dominique Scherer, Rajiv Kumar
Mutation Research/Reviews in Mutation Research (2010) Vol. 705, Iss. 2, pp. 141-153
Closed Access | Times Cited: 197
Vitiligo: A comprehensive overview
Lesley M. Felsten, Ali Alikhan, Vesna Petronic‐Rosic
Journal of the American Academy of Dermatology (2011) Vol. 65, Iss. 3, pp. 493-514
Closed Access | Times Cited: 178
Basal Cell and Squamous Cell Skin Cancers
Stanley J. Miller, Murad Alam, James Andersen, et al.
Journal of the National Comprehensive Cancer Network (2010) Vol. 8, Iss. 8, pp. 836-864
Closed Access | Times Cited: 170
Consensus for Nonmelanoma Skin Cancer Treatment
Arielle N.B. Kauvar, Terrence A. Cronin, Randall K. Roenigk, et al.
Dermatologic Surgery (2015) Vol. 41, Iss. 5, pp. 550-571
Open Access | Times Cited: 155
Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry
David Fiorentino, Vincent Ho, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology (2017) Vol. 77, Iss. 5, pp. 845-854.e5
Open Access | Times Cited: 151
Effective Narrow-Band UVB Radiation Therapy Suppresses the IL-23/IL-17 Axis in Normalized Psoriasis Plaques
Leanne M. Johnson-Huang, Mayte Suárez‐Fariñas, Mary Sullivan‐Whalen, et al.
Journal of Investigative Dermatology (2010) Vol. 130, Iss. 11, pp. 2654-2663
Open Access | Times Cited: 150
Trends of cutaneous squamous cell carcinoma in the Netherlands: Increased incidence rates, but stable relative survival and mortality 1989–2008
Loes M. Hollestein, Esther de Vries, Tamar Nijsten
European Journal of Cancer (2012) Vol. 48, Iss. 13, pp. 2046-2053
Open Access | Times Cited: 143
Management of Itch in Atopic Dermatitis
Judith Hong, Joerg Buddenkotte, Timothy G. Berger, et al.
Seminars in Cutaneous Medicine and Surgery (2011) Vol. 30, Iss. 2, pp. 71-86
Open Access | Times Cited: 143
Topical interventions for genital lichen sclerosus
Ching‐Chi Chi, Gudula Kirtschig, Maha Baldo, et al.
Cochrane library (2011) Vol. 2015, Iss. 10
Open Access | Times Cited: 135
Cancer risk in immune-mediated inflammatory diseases (IMID)
Rudi Beyaert, Laurent Beaugerie, Gert Van Assche, et al.
Molecular Cancer (2013) Vol. 12, Iss. 1
Open Access | Times Cited: 119
Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update
Shamir Geller, Haoming Xu, Mark Lebwohl, et al.
American Journal of Clinical Dermatology (2017) Vol. 19, Iss. 3, pp. 363-375
Open Access | Times Cited: 113
Consensus for Nonmelanoma Skin Cancer Treatment, Part II
Arielle N.B. Kauvar, Christopher J. Arpey, George J. Hruza, et al.
Dermatologic Surgery (2015) Vol. 41, Iss. 11, pp. 1214-1240
Closed Access | Times Cited: 112
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020*
Stephen Keohane, Jonathan Botting, P.G. Budny, et al.
British Journal of Dermatology (2020) Vol. 184, Iss. 3, pp. 401-414
Open Access | Times Cited: 89
Ultraviolet Radiation and Basal Cell Carcinoma: An Environmental Perspective
Yan Teng, Yong Yu, Sujing Li, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 63
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study
Teresa Battista, Lucia Gallo, Fabrizio Martora, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1940-1940
Open Access | Times Cited: 9
Diagnosis and Treatment of Pediatric Psoriasis: Current and Future
Kara N. Shah
American Journal of Clinical Dermatology (2013) Vol. 14, Iss. 3, pp. 195-213
Closed Access | Times Cited: 75
<p>Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events</p>
Smriti Subedi, Yu Gong, Youdong Chen, et al.
Drug Design Development and Therapy (2019) Vol. Volume 13, pp. 2491-2502
Open Access | Times Cited: 67
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure
April W. Armstrong, C. Paul, L. Puig, et al.
Dermatology and Therapy (2019) Vol. 10, Iss. 1, pp. 133-150
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top